...
首页> 外文期刊>American Journal of PharmTech Research >Avanafil: A Novel Agent for Management of Erectile Dysfunction, Its Clinical And Analytical Approach
【24h】

Avanafil: A Novel Agent for Management of Erectile Dysfunction, Its Clinical And Analytical Approach

机译:Avanafil:一种治疗勃起功能障碍的新型药物,其临床和分析方法

获取原文

摘要

ABSTRACT Erectile dysfunction is the sexual dysfunction characterized by inability to maintain an erection of penis during sexual performance. Oral phosphodiesterase type 5 inhibitors drugs are successful for treatment of impotence such as sildenafil, vardenafil, tadalafil, alprostadil and avanafil. Clinical trials reveals that avanafil have faster onset of action as well as higher specificity for phosphodiesterase type 5 inhibitors with fewer side effects in comparision of other oral phosphodiesterase type 5 inhibitors drugs. In case of analytical method only LC-MS/MS method has been done. There may be chances of analytical study of avanafil will be done in future by using various spectroscopy method. Keywords: Avanafil, Erectile dysfunction, Clinical Study, Analytical Approach
机译:摘要勃起功能障碍是一种性功能障碍,其特征是在性行为过程中无法维持阴茎的勃起。口服磷酸二酯酶5型抑制剂药物可成功治疗阳imp,如西地那非,伐地那非,他达拉非,前列地尔和阿伐那非。临床试验表明,与其他口服磷酸二酯酶5型抑制剂药物相比,阿伐那非对5型磷酸二酯酶抑制剂具有更快的起效以及更高的特异性。如果采用分析方法,则只能使用LC-MS / MS方法。将来可能会通过使用各种光谱学方法对阿伐那非进行分析研究。关键字:阿瓦那非,勃起功能障碍,临床研究,分析方法

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号